CT及MRI對(duì)原發(fā)性肝癌經(jīng)導(dǎo)管肝動(dòng)脈化療栓塞術(shù)后療效評(píng)估的對(duì)比
發(fā)布時(shí)間:2018-01-30 02:42
本文關(guān)鍵詞: 原發(fā)性肝癌 經(jīng)導(dǎo)管肝動(dòng)脈化療栓塞 CT MRI 出處:《實(shí)用醫(yī)學(xué)雜志》2017年18期 論文類型:期刊論文
【摘要】:目的比較CT及MRI對(duì)原發(fā)性肝癌經(jīng)導(dǎo)管肝動(dòng)脈化療栓塞(TACE)術(shù)后療效評(píng)估的價(jià)值。方法以45例原發(fā)性肝癌患者為研究對(duì)象,入選患者均采用TACE治療3~5次,治療后行CT、MRI病灶檢查及數(shù)字減影血管造影檢查,以數(shù)字減影血管造影檢查作為比較標(biāo)準(zhǔn),分析CT及MRI檢查的病灶殘余或病灶復(fù)發(fā)結(jié)果及腫瘤病灶包膜檢出情況。結(jié)果 TACE術(shù)后病灶殘余或病灶復(fù)發(fā)的掃描準(zhǔn)確率和掃描敏感性方面,CT掃描顯著低于MRI掃描,差異具有統(tǒng)計(jì)學(xué)意義(P0.05);TACE術(shù)后腫瘤包膜檢出率方面,CT掃描顯著低于MRI掃描,差異具有統(tǒng)計(jì)學(xué)意義(P0.05);TACE術(shù)后不同類型碘油沉積病灶殘余或病灶復(fù)發(fā)的檢出率方面,CT掃描顯著低于MRI掃描,差異具有統(tǒng)計(jì)學(xué)意義(P0.05)。結(jié)論與CT檢查方式比較,MRI檢測(cè)在TACE術(shù)后病灶殘余或病灶復(fù)發(fā)有著較高的的準(zhǔn)確率和敏感性,不僅可有效顯示腫瘤包膜情況,也檢測(cè)出不同類型碘油沉積的病灶殘余或病灶復(fù)發(fā),MRI對(duì)原發(fā)性肝癌TACE術(shù)后的療效評(píng)估優(yōu)于CT對(duì)原發(fā)性肝癌TACE術(shù)后的療效評(píng)估。
[Abstract]:Objective to compare the value of CT and MRI in evaluating the curative effect of transcatheter hepatic artery chemoembolization (TACEE) for primary liver cancer. All the patients were treated with TACE for 5 times. After the treatment, the focus of TACE and digital subtraction angiography were examined, and digital subtraction angiography was taken as the comparative standard. Results the accuracy and sensitivity of CT and MRI in the detection of residual or recurrent lesions and the detection of tumor capsule were analyzed. Results the accuracy and sensitivity of CT and MRI in detecting residual lesions or recurrence of lesions were analyzed. Ct scan was significantly lower than MRI scan, the difference was statistically significant (P 0.05). The detection rate of tumor capsule after TACE was significantly lower than that of MRI, and the difference was statistically significant (P 0.05). The detection rate of residual or recurrence of different types of lipiodol deposits after TACE was significantly lower than that of MRI. Conclusion compared with CT, MRI has a higher accuracy and sensitivity in detecting residual or recurrent lesions after TACE. Not only can the tumor capsule be effectively displayed, but also the residual or recurrent lesions of different types of lipiodol deposits can be detected. MRI was better than CT in evaluating the curative effect of TACE for primary liver cancer.
【作者單位】: 四川省醫(yī)學(xué)科學(xué)院·四川省人民醫(yī)院放射科;
【分類號(hào)】:R445.2;R730.44;R735.7
【正文快照】: 原發(fā)性肝癌是繼胃癌和食管癌后的第三大惡性腫瘤,全球年新增病例可高達(dá)60萬人,我國(guó)的原發(fā)性肝癌占比世界的50%以上,是嚴(yán)重威脅我國(guó)人民生命安全的疾病[1]。原發(fā)性肝癌具有明顯癥狀時(shí)一般都處于中晚期,且此時(shí)80%的患者均已不適合手術(shù)切除治療和化療,經(jīng)導(dǎo)管肝動(dòng)脈化療栓塞(TACE)
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 陳似霞;鐘麗;梁麗宏;蔣金利;;沙培林碘化油乳劑治療原發(fā)性肝癌的觀察與護(hù)理[J];中國(guó)癌癥防治雜志;2010年02期
2 王美書;張傳華;;原發(fā)性肝癌行肝動(dòng)脈化療栓塞術(shù)后的并發(fā)癥觀察及護(hù)理[J];中國(guó)醫(yī)藥導(dǎo)報(bào);2011年15期
3 張尚林;余業(yè)洗;;原發(fā)性肝癌自發(fā)破裂一例[J];中級(jí)醫(yī)刊;1958年01期
4 佃雪,
本文編號(hào):1475064
本文鏈接:http://sikaile.net/yixuelunwen/fangshe/1475064.html
最近更新
教材專著